- call +1-201-465-4211
- email sales@mrinsights.biz
Diagnostic instruments aid in the determination of causative agents of diseases.
Scope of the Report:
This report studies the Animal Therapeutics and Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Animal Therapeutics and Diagnostics market by product type and applications/end industries.
The animal therapeutics and diagnostics market is growing at a steady pace due to the increase in pet ownership worldwide, especially in the developing countries.
The global Animal Therapeutics and Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Animal Therapeutics and Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Bayer
Eli Lilly
Boehringer
Ingelheim
Merck
Zoetis
Ceva Santé Animale
Sanofi S.A.
Nutreco N.V.
Virbac S.A.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Animal Diagnostics Products
Instruments
Consumables
Animal Therapeutics Products
Anti-Parasitic Drugs and Antibiotics
Anti-Inflammatory Drugs
Anesthetics
Other Drugs
Market Segment by Applications, can be divided into
Companion Animals
Dogs
Cats
Other Companion Animals
Cattle
Pigs
Poultry
Sheep
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Animal Therapeutics and Diagnostics Market Overview
1.1 Product Overview and Scope of Animal Therapeutics and Diagnostics
1.2 Classification of Animal Therapeutics and Diagnostics by Types
1.2.1 Global Animal Therapeutics and Diagnostics Revenue Comparison by Types (2017-2023)
1.2.2 Global Animal Therapeutics and Diagnostics Revenue Market Share by Types in 2017
1.2.3 Animal Diagnostics Products
1.2.4 Instruments
1.2.5 Consumables
1.2.6 Animal Therapeutics Products
1.2.7 Anti-Parasitic Drugs and Antibiotics
1.2.8 Anti-Inflammatory Drugs
1.2.9 Anesthetics
1.2.10 Other Drugs
1.3 Global Animal Therapeutics and Diagnostics Market by Application
1.3.1 Global Animal Therapeutics and Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Companion Animals
1.3.3 Dogs
1.3.4 Cats
1.3.5 Other Companion Animals
1.3.6 Cattle
1.3.7 Pigs
1.3.8 Poultry
1.3.9 Sheep
1.4 Global Animal Therapeutics and Diagnostics Market by Regions
1.4.1 Global Animal Therapeutics and Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Animal Therapeutics and Diagnostics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Animal Therapeutics and Diagnostics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Animal Therapeutics and Diagnostics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Animal Therapeutics and Diagnostics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Animal Therapeutics and Diagnostics Status and Prospect (2013-2023)
1.5 Global Market Size of Animal Therapeutics and Diagnostics (2013-2023)
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Animal Therapeutics and Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Animal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eli Lilly
2.2.1 Business Overview
2.2.2 Animal Therapeutics and Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eli Lilly Animal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boehringer
2.3.1 Business Overview
2.3.2 Animal Therapeutics and Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Animal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Ingelheim
2.4.1 Business Overview
2.4.2 Animal Therapeutics and Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Ingelheim Animal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck
2.5.1 Business Overview
2.5.2 Animal Therapeutics and Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Animal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Zoetis
2.6.1 Business Overview
2.6.2 Animal Therapeutics and Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Zoetis Animal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Ceva Santé Animale
2.7.1 Business Overview
2.7.2 Animal Therapeutics and Diagnostics Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ceva Santé Animale Animal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi S.A.
2.8.1 Business Overview
2.8.2 Animal Therapeutics and Diagnostics Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sanofi S.A. Animal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Nutreco N.V.
2.9.1 Business Overview
2.9.2 Animal Therapeutics and Diagnostics Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Nutreco N.V. Animal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.10 Virbac S.A.
2.10.1 Business Overview
2.10.2 Animal Therapeutics and Diagnostics Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Virbac S.A. Animal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Animal Therapeutics and Diagnostics Market Competition, by Players
3.1 Global Animal Therapeutics and Diagnostics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Animal Therapeutics and Diagnostics Players Market Share
3.2.2 Top 10 Animal Therapeutics and Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Animal Therapeutics and Diagnostics Market Size by Regions
4.1 Global Animal Therapeutics and Diagnostics Revenue and Market Share by Regions
4.2 North America Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
4.3 Europe Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
4.5 South America Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
5 North America Animal Therapeutics and Diagnostics Revenue by Countries
5.1 North America Animal Therapeutics and Diagnostics Revenue by Countries (2013-2018)
5.2 USA Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
5.3 Canada Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
5.4 Mexico Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
6 Europe Animal Therapeutics and Diagnostics Revenue by Countries
6.1 Europe Animal Therapeutics and Diagnostics Revenue by Countries (2013-2018)
6.2 Germany Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
6.3 UK Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
6.4 France Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
6.5 Russia Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
6.6 Italy Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Animal Therapeutics and Diagnostics Revenue by Countries
7.1 Asia-Pacific Animal Therapeutics and Diagnostics Revenue by Countries (2013-2018)
7.2 China Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
7.3 Japan Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
7.4 Korea Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
7.5 India Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
8 South America Animal Therapeutics and Diagnostics Revenue by Countries
8.1 South America Animal Therapeutics and Diagnostics Revenue by Countries (2013-2018)
8.2 Brazil Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
8.3 Argentina Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
8.4 Colombia Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Animal Therapeutics and Diagnostics by Countries
9.1 Middle East and Africa Animal Therapeutics and Diagnostics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
9.3 UAE Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
9.4 Egypt Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
9.6 South Africa Animal Therapeutics and Diagnostics Revenue and Growth Rate (2013-2018)
10 Global Animal Therapeutics and Diagnostics Market Segment by Type
10.1 Global Animal Therapeutics and Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Global Animal Therapeutics and Diagnostics Market Forecast by Type (2018-2023)
10.3 Animal Diagnostics Products Revenue Growth Rate (2013-2023)
10.4 Instruments Revenue Growth Rate (2013-2023)
10.5 Consumables Revenue Growth Rate (2013-2023)
10.6 Animal Therapeutics Products Revenue Growth Rate (2013-2023)
10.7 Anti-Parasitic Drugs and Antibiotics Revenue Growth Rate (2013-2023)
10.8 Anti-Inflammatory Drugs Revenue Growth Rate (2013-2023)
10.9 Anesthetics Revenue Growth Rate (2013-2023)
10.10 Other Drugs Revenue Growth Rate (2013-2023)
11 Global Animal Therapeutics and Diagnostics Market Segment by Application
11.1 Global Animal Therapeutics and Diagnostics Revenue Market Share by Application (2013-2018)
11.2 Animal Therapeutics and Diagnostics Market Forecast by Application (2018-2023)
11.3 Companion Animals Revenue Growth (2013-2018)
11.4 Dogs Revenue Growth (2013-2018)
11.5 Cats Revenue Growth (2013-2018)
11.6 Other Companion Animals Revenue Growth (2013-2018)
11.7 Cattle Revenue Growth (2013-2018)
11.8 Pigs Revenue Growth (2013-2018)
11.9 Poultry Revenue Growth (2013-2018)
11.10 Sheep Revenue Growth (2013-2018)
12 Global Animal Therapeutics and Diagnostics Market Size Forecast (2018-2023)
12.1 Global Animal Therapeutics and Diagnostics Market Size Forecast (2018-2023)
12.2 Global Animal Therapeutics and Diagnostics Market Forecast by Regions (2018-2023)
12.3 North America Animal Therapeutics and Diagnostics Revenue Market Forecast (2018-2023)
12.4 Europe Animal Therapeutics and Diagnostics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Animal Therapeutics and Diagnostics Revenue Market Forecast (2018-2023)
12.6 South America Animal Therapeutics and Diagnostics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Animal Therapeutics and Diagnostics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Animal Therapeutics and Diagnostics Picture
Table Product Specifications of Animal Therapeutics and Diagnostics
Table Global Animal Therapeutics and Diagnostics and
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
